No Survival Benefit of Tumor Debulking for Patients With Multiorgan Metastatic Colorectal Cancer
A phase 3 trial has found that there is no survival benefit for tumor debulking in addition to palliative combination chemotherapy.
Read More
Author: Rebecca Shover
Adding Abemaciclib to Fulvestrant Improves Progression-Free Survival in Advanced HR+/HER2-Negative Breast Cancer After Progression on CDK4/6 Inhibitor and Endocrine Therapy
Abemaciclib in combination with fulvestrant can benefit progression free survival rates in patients with HR+/HER2-negative breast cancer.
Read More
First-Line Lorlatinib Provides Unprecedented Improvement for Patients With Advanced ALK+ NSCLC
An analysis has found that lorlatinib did not reach median progression free survival rates.
Read More
IV Iron for Patients With HFrEF and Iron Deficiency: Efficacy, Outcomes, and Future Directions
Recent studies highlight the growing interest surrounding the use of IV iron for patients with HFrEF and iron deficiency.
Read More
Tardive Dyskinesia eBook
A curated ebook on tardive dyskinesia featuring recent studies, findings, and opinions from thought leaders.
Read More
Study Shows Disparities in Palliative Care Use for Patients With Hepatocellular Carcinoma
Researchers at the 2024 ASCO Annual Meeting found racial and ethnic disparities in palliative care use among patients with advanced hepatocellular carcinoma.
Read More
Fixed-Duration Regimen Substantially Benefits PFS in Patients With CLL/SLL
Fixed duration ibrutinib plus venetoclax benefited survival outcomes in patients with high-risk CLL/SLL over more than 5 years of follow-up.
Read More
Examining Mortality in Patients With Multiple Myeloma and the Role of Infectious Diseases
Investigators examined the changes in mortality rates due to COVID-19, influenza, and pneumonia in patients with MM.
Read More
Survival Outcomes in Early-Stage NSCLC With Rare Mutations
The treatment landscape for non-small cell lung cancer has significantly evolved with the advent of targeted therapies.
Read More
10 Predictions From the Beginning of 2024: Are They Still True?
In the Physician’s Weekly podcast‘s first episode of 2024, host Rachel Giles, MD, and PW editorial board member Alex McDonald, MD, discussed their perspectives on anticipated medical breakthroughs.
Read More
Medical Fiction: Memorial Day and a Flag Misfortune
Dr. Leesa Cornell, CMO, confronts Benjamin Huffman, insurance executive, at a Memorial Day picnic, where tensions rise over insurer policies and ED crowding.
Read More
Q&A: Avoidant/Restrictive Food Intake Disorder in Crohn’s Disease and Ulcerative Colitis
In inflammatory bowel disease, empiric or overall food avoidance increases the risk for food avoidance and avoidant/restrictive food intake disorder.
Read More
ASCO Voices 2024
ASCO Voices has become an anticipated staple of the conference. It is an opportunity for physicians to share their platform and experiences on a scale unlike any other.
Read More
ASCO Voices 2024
ASCO Voices has become an anticipated staple of the conference. It is an opportunity for physicians to share their platform and experiences on a scale unlike any other.
Read More
ASCO Voices 2024
ASCO Voices has become an anticipated staple of the conference. It is an opportunity for physicians to share their platform and experiences on a scale unlike any other.
Read More
Places to Visit in Chicago
Are you traveling to Chicago for ASCO? Here’s some places to visit.
Read More
Places to Visit in Chicago
Are you traveling to Chicago for ASCO? Here’s some places to visit.
Read More